Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease)

According to recommendations of the 6th WHO Advisory Committee on Buruli ulcer, directly observed treatment with the combination of rifampin and streptomycin, administered daily for 8 weeks, was recommended to 310 patients diagnosed with Buruli ulcer in Pobè, Bénin. Among the 224 (72%) eligible pati...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chauty, Annick, Ardant, Marie-Françoise, Adeye, Ambroise, Euverte, Hélène, Guédénon, Augustin, Johnson, Christian, Aubry, Jacques, Nuermberger, Eric, Grosset, Jacques
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2007
Soggetti:
Clinical Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2151409/
https://ncbi.nlm.nih.gov/pubmed/17526760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00175-07
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi